TVTX Sale Disclosure
Reed Elizabeth E · SEC Form 4 · Filed Sep 17, 2026
Sale
Calculated transaction value
$868.96K
Reed Elizabeth E Chief Legal Officer And GC
TVTX
Travere Therapeutics
TVTX
Transaction date
Sep 15, 2026
Public filing date
Sep 18, 2026
Filing lag
Filed 3 days later
TVTX daily price context
Close on/before transaction
$62.51
Sep 15, 2026
Close before public filing
$64.74
Sep 17, 2026
Return since public filing
-3.06%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 13,874 shares @ $62.63
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001283303-26-000010
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$2.92M
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 15, 2026 | $579.75K |
| Travere Therapeutics, Inc. TVTX | Sale | Sep 15, 2026 | $1.36M |
| Travere Therapeutics, Inc. TVTX Current | Sale | Sep 15, 2026 | $868.96K |
| Travere Therapeutics, Inc. TVTX | Sale | Sep 15, 2026 | $89.17K |
| Travere Therapeutics, Inc. TVTX | Sale | Sep 15, 2026 | $19.59K |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 15, 2026 | $0 |